Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03016702 · ClinicalTrials.gov registry record · NA

The Cognitive Resilience Study

A NA study of Alzheimer Disease, sponsored by Duke University.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT03016702 is a NA study of Alzheimer Disease that has completed, run by Duke University. The registered enrollment target is 29 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03016702, a NA study of Alzheimer Disease, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test whether two new cognitive "stress tests" may help distinguish between people at lower or higher genetic risk of Alzheimer's Disease. The investigators are trying to understand how these cognitive "stress tests" work in people who have not been diagnosed with Alzheimer's Disease and are not exhibiting symptoms of Alzheimer's Disease. Study subjects will undergo testing of memory and executive function during functional magnetic resonance image (fMRI) of the brain and also during a walking test.

Conditions Studied

Alzheimer Disease

Interventions

  • OTHER Cognitive stress tests during functional MRI
  • OTHER Cognitive stress tests during gait task

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2017-02-27
Est. Completion 2017-08-09
Phase NA

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03016702

The ClinicalTrials.gov registry entry for NCT03016702 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Cognitive stress tests during functional MRI is the first listed.

NCT03016702 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03016702 about?

NCT03016702 is a clinical study titled "The Cognitive Resilience Study". The purpose of this study is to test whether two new cognitive "stress tests" may help distinguish between people at lower or higher genetic risk of Alzheimer's Disease. The investigators are trying to understand how these cognitive "stress tests" work in people who have not been diagnosed with Alzh...

What is the current status of trial NCT03016702?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-02-27. Estimated completion is 2017-08-09.

What conditions does trial NCT03016702 study?

This clinical trial studies the following conditions: Alzheimer Disease.

What interventions are being tested in trial NCT03016702?

The interventions under investigation include: Cognitive stress tests during functional MRI (OTHER), Cognitive stress tests during gait task (OTHER).

Who is sponsoring clinical trial NCT03016702?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03016702 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.